e-learning
resources
Madrid 2019
Monday, 30.09.2019
COPD treatment: cardiovascular, oxygen and vaccination studies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary haemodynamic disorders in chronic obstructive pulmonary disease
V. Calancea (Chisinau, Republic of Moldova), E. Terna (Chisinau, Republic of Moldova), T. Dumitras (Chisinau, Republic of Moldova), D. Barba (Chisinau, Republic of Moldova), I. Cosciug (Chisinau, Republic of Moldova), S. Matcovschi (Chisinau, Republic of Moldova)
Source:
International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Session:
COPD treatment: cardiovascular, oxygen and vaccination studies
Session type:
Thematic Poster
Number:
2464
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Calancea (Chisinau, Republic of Moldova), E. Terna (Chisinau, Republic of Moldova), T. Dumitras (Chisinau, Republic of Moldova), D. Barba (Chisinau, Republic of Moldova), I. Cosciug (Chisinau, Republic of Moldova), S. Matcovschi (Chisinau, Republic of Moldova). Pulmonary haemodynamic disorders in chronic obstructive pulmonary disease. 2464
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Pulmonary hypertension associated with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 656s
Year: 2006
Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 512s
Year: 2005
Rhinovirus-infection in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002
Pulmonary endothelial dysfunction in chronic obstructive pulmonary disease
Source: ERS Research Seminar 2016 - Pulmonary Vascular Endothelium: Orchestra Conductor in Respiratory Diseases - Highlights from Basic Research to Therapy
Year: 2016
Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Pulmonary hypertension and exercise capacity in patients with severe chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 285s
Year: 2002
Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2014; 65: 1-17
Year: 2014
Chronic obstructive pulmonary disease
Source: Eur Respir Mon; 2009: 45: 25–31
Year: 2009
Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2015; 70: 80-98
Year: 2015
Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2013; 62: 1-18
Year: 2013
Bronchodilators in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=266
Year: 2006
Inflammation and depression in chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 718s
Year: 2007
Comorbidities in the course of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011
Pulmonary hemodynamics in chronic obstructive pulmonary disease with patients suffering from parasitic invasion
Source: Eur Respir J 2004; 24: Suppl. 48, 59s
Year: 2004
Anemia in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012
Chronic obstructive pulmonary disease and pulmonary embolism
Source: Virtual Congress 2021 – Spanish/Portuguese programme 2021
Year: 2021
Pulmonary rehabilitation in interstitial lung diseases compared with chronic obstructive pulmonary disease
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019
Systemic inflammation in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 5S-13S
Year: 2003
Endothelial dysfunction and pulmonary hypertension in chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Telemedicine in chronic obstructive pulmonary disease
Source: Breathe 2016; 12: 350-356
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept